NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,792,000 | +6.7% | 20,526 | +0.7% | 3.14% | -12.1% |
Q1 2020 | $1,680,000 | -15.7% | 20,384 | -3.1% | 3.57% | +7.9% |
Q4 2019 | $1,993,000 | +8.8% | 21,034 | -0.1% | 3.30% | +1.3% |
Q3 2019 | $1,831,000 | -17.6% | 21,064 | -13.5% | 3.26% | -2.6% |
Q2 2019 | $2,223,000 | -5.6% | 24,350 | -0.6% | 3.35% | -8.7% |
Q1 2019 | $2,355,000 | +10.3% | 24,496 | -1.6% | 3.67% | -3.8% |
Q4 2018 | $2,135,000 | -0.9% | 24,886 | -0.5% | 3.81% | +14.7% |
Q3 2018 | $2,155,000 | +9.3% | 25,020 | -4.1% | 3.32% | +5.4% |
Q2 2018 | $1,972,000 | -6.4% | 26,089 | +0.2% | 3.15% | -6.0% |
Q1 2018 | $2,106,000 | -7.7% | 26,035 | -4.2% | 3.36% | +0.7% |
Q4 2017 | $2,282,000 | -11.8% | 27,169 | -9.8% | 3.33% | -1.7% |
Q3 2017 | $2,586,000 | +3.2% | 30,134 | +0.4% | 3.39% | +0.4% |
Q2 2017 | $2,505,000 | +12.4% | 30,004 | +0.0% | 3.38% | +6.7% |
Q1 2017 | $2,229,000 | +3.0% | 30,003 | +1.0% | 3.16% | -1.9% |
Q4 2016 | $2,165,000 | -8.0% | 29,713 | -0.3% | 3.23% | -2.2% |
Q3 2016 | $2,353,000 | -4.9% | 29,803 | -0.7% | 3.30% | -4.5% |
Q2 2016 | $2,475,000 | +14.3% | 30,000 | +0.4% | 3.45% | +13.2% |
Q1 2016 | $2,165,000 | -2.3% | 29,875 | +16.1% | 3.05% | -16.7% |
Q4 2015 | $2,215,000 | +32.6% | 25,740 | +41.6% | 3.66% | -19.4% |
Q3 2015 | $1,671,000 | -5.6% | 18,180 | +1.0% | 4.54% | +1.3% |
Q2 2015 | $1,770,000 | +0.5% | 18,005 | +0.8% | 4.49% | +1.7% |
Q1 2015 | $1,761,000 | +31.2% | 17,855 | +23.3% | 4.41% | -3.2% |
Q4 2014 | $1,342,000 | -2.2% | 14,485 | -0.6% | 4.55% | -4.0% |
Q3 2014 | $1,372,000 | +4.5% | 14,575 | +0.4% | 4.74% | +5.8% |
Q2 2014 | $1,313,000 | +6.1% | 14,510 | -0.2% | 4.48% | +4.5% |
Q1 2014 | $1,238,000 | +5.7% | 14,545 | -0.1% | 4.29% | +5.0% |
Q4 2013 | $1,171,000 | +14.4% | 14,565 | +9.1% | 4.09% | -1.0% |
Q3 2013 | $1,024,000 | +8.6% | 13,350 | 0.0% | 4.13% | -2.4% |
Q2 2013 | $943,000 | -0.8% | 13,350 | 0.0% | 4.23% | +2.0% |
Q1 2013 | $951,000 | +4.5% | 13,350 | -7.1% | 4.15% | -4.4% |
Q4 2012 | $910,000 | – | 14,370 | – | 4.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |